NCT04527328View on ClinicalTrials.gov

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

June 4, 2021

Study Completion Date

June 4, 2021

Conditions
Cognitive ImpairmentEnd Stage Renal Disease
Interventions
DEVICE

AKST1210

AKST1210

OTHER

Sham Control (No Intervention)

A covered surrogate object of similar size and shape as the investigational device

PROCEDURE

Hemodialysis

Hemodialysis

Trial Locations (4)

32809

Orlando Clinical Research Center, Orlando

78251

US Renal Care Kidney Research, San Antonio

91324

Valley Renal Medical Group, Northridge

91344

Renal Consultants Medical Group, Granada Hills

Sponsors

Lead Sponsor

Alkahest, Inc.
All Listed Sponsors
lead

Alkahest, Inc.

INDUSTRY